MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of...
$25,552K
Proceeds from exercises
of stock options
$222K
Net cash provided by
(used in) investing...
$16,965K
Net cash provided by
financing activities
$222K
Canceled cashflow
$8,587K
Net increase
(decrease) in cash and cash...
$498K
Canceled cashflow
$16,689K
Purchases of
available-for-sale marketable...
$8,485K
Purchases of property,
equipment and leasehold...
$102K
Stock-based compensation
$2,191K
Operating lease
right-of-use assets
$105K
Depreciation and
amortization
$34K
Net cash used in
operating activities
-$16,689K
Canceled cashflow
$2,330K
Net loss
-$13,192K
Prepaid expenses and
other current assets
$2,838K
Accounts payable
-$1,483K
Accrued expenses and
other liabilities
-$1,075K
Accretion of
available-for-sale marketable...
$431K
Back
Back
Cash Flow
source: myfinsight.com
Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. (TRVI)